SUTRO Trademark

Trademark Overview


On Friday, March 24, 2023, a trademark application was filed for SUTRO with the United States Patent and Trademark Office. The USPTO has given the SUTRO trademark a serial number of 97855620. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 21, 2024. This trademark is owned by Sutro Biopharma, Inc.. The SUTRO trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacturing of pharmaceuticals and therapeutic agents for medical use; Custom manufacturing of bacterial lysate preparations and bacterial extract preparations

Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathways; Pharmaceutical and biological preparations for use in oncology; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer, cardiovascular, hematopoietic, central nervous system, autoimmune, infectious, skin and skin structure, bone, genetic, endocrine or metabolic diseases, disorders, and conditions; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, and engineered antibodies for destroying tumor cells and stimulating immune response; Vaccines; Bacterial lysate preparations and bacterial extract preparations, for use in the cell free production of therapeutic proteins and peptides for medical use

Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases
sutro

General Information


Serial Number97855620
Word MarkSUTRO
Filing DateFriday, March 24, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements


Goods and ServicesCustom manufacturing of pharmaceuticals and therapeutic agents for medical use; Custom manufacturing of bacterial lysate preparations and bacterial extract preparations
Description of MarkThe mark consists of the word SUTRO with the letter O displayed as an elongated crescent with a circle placed in the open portion of the crescent.
Goods and ServicesPharmaceutical and biological preparations for the immune system targeting immuno-oncology pathways; Pharmaceutical and biological preparations for use in oncology; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer, cardiovascular, hematopoietic, central nervous system, autoimmune, infectious, skin and skin structure, bone, genetic, endocrine or metabolic diseases, disorders, and conditions; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, and engineered antibodies for destroying tumor cells and stimulating immune response; Vaccines; Bacterial lysate preparations and bacterial extract preparations, for use in the cell free production of therapeutic proteins and peptides for medical use
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, April 16, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateSunday, April 16, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, April 16, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSutro Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameSutro Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Tuesday, March 28, 2023NEW APPLICATION ENTERED
Sunday, April 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 18, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 19, 2023ASSIGNED TO EXAMINER
Tuesday, March 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 20, 2023NON-FINAL ACTION WRITTEN
Wednesday, December 20, 2023NON-FINAL ACTION E-MAILED
Wednesday, December 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 16, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 16, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, April 16, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 17, 2024ASSIGNED TO LIE
Wednesday, April 17, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, April 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED